Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
mAb Beta-40
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-56
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
ChAdOx1 nCoV-19
Emergency use authorization Experimental Vaccine Jan/04/2022
hrsACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
BRII-198
Potential treatment - theoretical effect Experimental Antiviral Dec/23/2021
BRII-196
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
BBIBP-CorV
Potential treatment - clinical evidence Experimental Vaccine Dec/23/2021
S2N12
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
S2X324
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
S2H97
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
S2X259
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
S2N28
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
Gam-COVID-Vac
Emergency use authorization Experimental Vaccine Dec/23/2021
mAb Beta-22
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2021
mAb Beta-27
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2021
ALD-R491
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/12/2021
LSNME/SW1
Potential treatment - pre-clinical evidence Experimental Vaccine Oct/01/2021
hACE21−740-Fc
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/11/2021
scFv-IL6R-Fc
Potential treatment - theoretical effect Experimental Other treatment Jun/11/2021
VH-Fc ab8
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021